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Abstract One of the major factors that limits the treat-
ment effectiveness for gliomas is the presence of the
blood–brain barrier (BBB) which protects inﬁltrating gli-
oma cells from the effects of anti-cancer agents. Circulat-
ing monocytes/macrophages (Ma) have a natural ability to
traverse the intact and compromised BBB and loaded with
anti cancer agents could be used as vectors to target tumors
and surrounding tumor inﬁltrated tissue. Nanoshells (NS)
are composed of a dielectric core (silica) coated with an
ultrathin gold layer which converts absorbed near-infrared
light (NIR) to heat with an extremely high efﬁcacy and
stability. We have investigated the effects of exposure to
laser NIR on multicell human glioma spheroids inﬁltrated
with empty (containing no nanoshells) or nanoshell loaded
macrophages. Our results demonstrated that; (1) macro-
phages could efﬁciently take up bare or coated (PEGylated)
gold NS: (2) NS loaded macrophages inﬁltrated into gli-
oma spheroids to the same or, in some cases, to a greater
degree than empty Ma; (3) NIR laser irradiation of spher-
oids incorporating NS loaded macrophages resulted in
complete growth inhibition in an irradiance dependent
manner, and (4) spheroids inﬁltrated with empty macro-
phages had growth curves identical to untreated control
cultures. The results of this study provide proof of concept
for the use of macrophages as a delivery vector of NS into
gliomas for photothermal ablation and open the possibility
of developing such regimens for patient treatment.
Keywords Gold nanoshells  Macrophage 
Nanoshell delivery  Blood brain barrier  Gliomas
Introduction
Malignant gliomas are the most common primary brain
tumors in adults. The most aggressive of these tumors,
glioblastoma multiforme (GBM), are characterized by a
number of histological features including signiﬁcant pro-
liferation, invasion, angiogenesis and necrosis. Even with
substantial improvements in conventional treatments con-
sisting of surgery, radiation therapy and chemotherapy, the
prognosis for patients with this disease has not improved
signiﬁcantly over the past four decades: median survival is
approximately 12–18 months. One of the major factors that
limits the treatment effectiveness for gliomas is the pres-
ence of the blood–brain barrier (BBB) which protects
inﬁltrating glioma cells from the effects of anti-cancer
agents [1–3]. Failure to eradicate these inﬁltrating cells
invariably results in tumor recurrence and is responsible for
the dismal prognosis of GBM patients.
The BBB is formed by tightly connected brain capillary
endothelial cells that prevent passage of most biological
molecules. This impermeability prevents harmful sub-
stances in the blood plasma from entering the brain.
Unfortunately this protective barrier also prevents anti-
cancer agents from reaching inﬁltrating glioma cells that
have migrated from the solid tumor mass. Nearly all large-
molecule pharmaceutics (peptides, recombinant proteins,
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small molecules do not cross the BBB [4, 5].
Circulating monocytes/macrophages (designated Ma in
this paper) have a natural ability to traverse the intact and
compromised BBB and undergo differentiation into long-
lived brain-resident macrophages and microglia [6].
Tumor-associated Ma are frequently found in and around
GBM in both experimental animals and patient biopsies
[7–10]. Additionally, intravenously injected Ma loaded
with iron oxide nanoparticles have been shown to accu-
mulate in and at the border of experimental brain tumors
[11]. These observations indicate local synthesis of chemo
attractive factors in gliomas and that inﬂammatory cells
can pass through the blood brain tumor barrier (BBTB) as
well as the brain adjacent to tumor (BAT) region where the
concentration of inﬁltrating glioma cells is greatest. Ma
loaded with drugs, nanoparticles or photosensitizers could
therefore be used as vectors to target tumors and sur-
rounding tumor inﬁltrated tissue [11–15].
Nanoshells are a new class of optically tunable nano-
particle (designated NS) composed of a dielectric core
(silica) coated with an ultrathin metallic layer (gold) [16–
18]. By adjusting the relative core and shell thickness,
nanoshells can be manufactured to absorb or scatter light at
near-infrared (NIR) wavelengths, a region of light where
optical penetration through tissue is optimal. Furthermore,
the metal shell converts absorbed NIR to heat with an
efﬁcacy and stability that far exceeds that of conventional
dyes. Not only do gold–silica nanoshells have advanta-
geous optical properties, but their size allows them to be
taken up and accumulated in quantity in Ma.
In the study reported here we have investigated the
effects of exposure to NIR on multicell human glioma
spheroids inﬁltrated with empty (containing no NS) or NS
loaded Ma. Spheroid cultures were used since they are well
suited to studies of the direct effects on tumors of modal-
ities like photodynamic therapy (PDT) or photothermal
therapy (PTT) without the effects of circulatory or immu-
nological inﬂuences [19]. The results of this study provide
proof of concept for the use of macrophages as a delivery
vector of NS into gliomas for photothermal ablation and
open the possibility of developing such regimens for
patient treatment.
Materials and methods
Cell cultures of brain tumor spheroid and macrophages
The human grade IV glioma cell line (ACBT) and murine
Ma P388-D1 (ATCC, CCL-46) were used in all experi-
ments. The cells were cultured in Dulbecco’s Modiﬁed
Eagle Media (DMEM, Gibco, Carlsbad, CA) with high
glucose and supplemented with 2 mM L-glutamine, gen-
tamycin (100 mg/ml), and 2% heat-inactivated fetal bovine
serum (Gibco). Cells were maintained at 37C in a 7.5%
CO2 incubator.
Nanoshells
The gold nanoshells (NS) used in this study consisted of a
120 nm silica core with a 12–15 nm gold shell (Nano-
spectra Biosciences, Inc., Houston, Texas). The resultant
optical absorption peak was between 790 and 820 nm for
both bare and PEGylated particles. The absorbance curves
of bare (a) and PEGylated (b) nanoshell solutions as sup-
plied by the manufacturer are shown in Fig. 1. The solu-
tions were found to have an optical density (O.D.) of 1.6 at
k = 819 nm for bare nanoshells (no dilution) and 1.22 at
k = 795 nm for PEGylated nanoshells (1009 dilution).
The uptake of nanoshells in murine macrophages was
studied using a UV–Vis-NIR spectrophotometer. 5 9 10
6
P388-D1 cells were incubated with either 4.3 9 10
9 bare
nanoshells or 1.4 9 10
11 PEGylated nanoshells (1 ml) for
24 h at 37C in 5%CO2. Following incubation, macro-
phages were transferred to 15-ml centrifuge tubes, cen-
trifuged at 600 rpm for 7 min, and then washed twice
with PBS to remove excess particles. The ﬁnal cell pellet
was suspended in 3 ml of DMEM, and the absorbance of
the resultant cellular suspension measured with a Varian
UV–Vis-NIR spectrophotometer (Cary 6000i, Varian,
USA). Absorbance was measured between 600 and
1100 nm, which covers the broad absorption peak of both
bare and PEGylated nanoshells. To calculate % uptake of
NS, reference solutions containing NS in the absence of
Ma were used, and were prepared in the same media as
that used for macrophage incubation, and at the same
dilution ratio. Background correction was necessary to
Fig. 1 The absorbance curves of PEGylated nanoshell solutions as
supplied by the manufacturer. The solution was found to have an
optical density (O.D.) 1.22 at k = 795 nm (1009 dilution)
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123obtain absorbance values corresponding to NS only, i.e.
without medium interference. Consequently, solutions
prepared by substituting the NS volume added with de-
ionized water were measured, and their absorbance values
subtracted from the NS solution absorbance values to give
the pure absorbance of the NS. The absorbance of NS
only, i.e. without macrophage interference is needed to
calculate % uptake. Consequently, macrophages incubated
under similar conditions (same number, total volume,
incubation time) in absence of NS were similarly washed
and suspended in 3 ml DMEM. The resulting solution
was measured, and its absorbance value subtracted from
those of the macrophage groups to give the pure absor-
bance of the incorporated nanoparticles. % uptake of
nanoshells was calculated by the absorbance of incorpo-
rated nanoshells at k = 819 nm divided by the absoption
of the nanoshells alone 9100.
Generation of tumor cell and hybrid tumor/Ma
spheroids
Spheroids were formed by a modiﬁcation of the centrifu-
gation method ﬁrst described by Ivascu and Kubbies [20].
Tumor spheroids were generated with 5 9 10
3 cells in
200 ll of culture medium per well of an ultra-low attach-
ment surface 96-well round bottomed plate (Corning Inc.,
NY). To form hybrid spheroids, Ma were mixed with tumor
cells at ratios of tumor cells:Ma ranging from 2:1 to 10:1
(50–10%). In all cases, 5 9 10
3/well of tumor cells were
used. Empty and NS loaded macrophages were treated,
prior to their addition to the tumor cells, with mitomycin C
to prevent cell division and their contribution to spheroid
growth. The plates were centrifuged at 10009g for 10 min.
Immediately following centrifugation the tumor cells
formed into a disk shape. The plates were maintained at
37C in a 7.5% CO2 incubator for 48 h to allow them to
take on the usual 3 dimensional spheroid form.
Fluorescence labeling of Ma
20 9 10
6 Ma/ml were labeled with ﬂuorescence cell
tracking dye PKH26GLred (SigmaAldrich, St. Louis, MO).
After washing twice in basal medium without serum, cell
pellets were resuspended in 1 ml Diluent C (an iso-oso-
motic aqueous solution without physiologic salts or buf-
fers) by gentle pipetting. The cell suspension in Diluent C
was rapidly added to 1 ml of 29 dye concentration at
4 9 10
-6 molar by gentle pipetting. After 5 min of incu-
bation at room temperature, an equal amount of FBS was
added to stop the staining process. Additional three washes
with 10 ml complete growth medium each to remove any
residue unbounded dyes were carried out to complete the
labeling process.
Uptake of nanoshells in labeled Ma
Labeled Ma were seeded in 35 mm cell culture dishes at 10
6
Ma in 2 ml of the culture medium. The dishes were incu-
bated overnight to allow the cells to settle and adhere to the
plastic. Culture medium was exchanged for 100 ll of either
bare (3.2 9 10
9 particles/ml) or PEGylated (2.8 9 10
11
particles/ml) nanoshells colloid in 1.9 ml of culture med-
ium. The Ma were incubated for 24 h at 37C, rinsed three
times with Hanks’ Balanced Salt Solution with calcium
chloride and magnesium chloride (HBSS, Gibco, Carlsbad,
CA) to wash away the excess of non-ingested nanoshells.
Nanoshell laden Ma were then detached with trypsin,
washed and counted.
Photothermal treatment (PTT)
Individual spheroids in each well of a 96 well round bot-
tomed plate were irradiated with 810 nm laser light
(CoherentInc., SantaClara,CA) atirradiancesrangingfrom
2 to 28 W/cm
2 with a laser spot size approximately 3 or
5 mm diameter. Laser treatment lasted for exposure inter-
valsof1,5or10 min.Atvarioustimeintervalsrangingfrom
1 to 14 days following PTT, the cells were stained using a
combination of Hoechst 33342 and Ethidium Homodimer 1
(InvitrogenH1399,Carlsbad,CA)andwerevisualizedusing
aninvertedZeisslaser-scanningmicroscope(LSM410,Carl
Zeiss, Jena, Germany). This system allows the differential
visualization of cell nuclei using confocal and two-photon
microscopy. Simultaneously detected blue and red emis-
sionswereisolatedbyusingBP390–465IRandBP565–615
IR band pass ﬁlters, respectively. Fluorescent images were
pseudo-colored blue and red.
Statistical analysis
The effect of PTT on the growth of spheroids containing; 1.
No Ma, 2. empty Ma or 3. NS loaded Ma was compared
using the Student’s t-test for unrelated samples. A bidi-
rectional hypothesis was applied and signiﬁcance was
considered when the P-value was less than 0.05.
Results
Macrophage endocytosis of bare or PEGylated
nanoshells
Bright Field TEM images of murine macrophages incu-
bated for 24 h with nanoshells revealed extensive intra-
cellular presence of the nanoparticles (Fig. 2). Nanoshells,
in small aggregates, were inside vacuoles which were
dispersed throughout the cellular cytoplasm (white arrows).
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could also be visualized with 2 photon microscopy as
shown in Fig. 3.
The % uptake of PEGylated nanoshells in murine mac-
rophages was lower (3.96%) than that of bare nanoshells
(15.74%). However, the PEGylated nanoshell solution was
available in a much higher concentration since they have a
much lower tendency to aggregate compared to bare
nanoshells. Comparison was therefore between the respec-
tive numbers of nanoshells taken up by a given number of
macrophages (5 million in both groups). Ma incorporated
59 9 10
8 PEGylated nanoshells versus only 6.8 9 10
8 bare
nanoshells. In other words, the total amount of PEGylated
nanoshells taken up by the macrophages was more than 8
times that of bare nanoshells. PEGylated nanoshells were
therefore used in all subsequent experiments.
Generation of hybrid spheroids
Hybrid spheroids were produced by the centrifugation
method containing varying tumor to macrophage cell ratios
ranging from a 2:1 to a 10:1 ratio. A typical hybrid
spheroid produced in this manner with a tumor cell:Ma
ratio of 2:1 is shown in Fig. 4a. The macrophages were
labeled with PKH26GLRed to allow their identiﬁcation
with two photon ﬂuorescent microscopy within the spher-
oid. As can be seen from the ﬁgure the macrophages were
more or less equally distributed throughout the spheroid at
this ratio. No Ma were observed outside the spheroid
indicating that all were incorporated during centrifugation.
By careful control of the number of Ma mixed with the
tumor cells (ratio TC:MA 10:1) and the centrifugation
RPM, it proved possible to generate spheroids where the
Ma accumulated in the core of the spheroid.
Migration of empty or NS-loaded macrophages
into preformed spheroids
ACBT human tumor spheroids were generated by the
centrifugation method as previously described. Forty-eight
hours following their generation, 2 9 10
4/ml PKH26GL
Red labeled empty or nanoshell loaded Ma were added to
the wells and co incubated for 4, 18 and 36 h. The number
of labeled Ma that had inﬁltrated into the spheroids
increased for the ﬁrst 12 h of co-incubation and then
appeared to approach saturation levels. The distribution of
inﬁltrating labeled Ma (Fig. 4b, c) assayed after 12 h of co-
incubation was similar to that seen in the hybrid spheroids
(Fig. 4a). Loaded macrophages appeared to inﬁltrate at an
increased initial rate and penetrated deeper into the
spheroid during the ﬁrst 2 h of co-incubation. The majority
of empty Ma were found in the outer rim of the spheroid at
the 2 h time point, while in contrast, NS loaded Ma had a
much deeper penetration during this initial incubation
period. By the 12 h time point, no signiﬁcant differences
between empty and loaded Ma could be determined when
comparing either number of Ma or their penetration depth
(data not shown).
Effects of PTT on hybrid and inﬁltrated spheroids
Hybrid or inﬁltrated spheroids containing either empty or
NS loaded Ma were exposed to NIR irradiation of
increasing irradiances. Spheroid cultures were stained with
the live/dead markers Hoechst 33342 and Ethidium
Homodimer 24 h before evaluation by laser scanning
microscopy. As can be seen from Fig. 5 there was a
striking difference in spheroid survival between those
containing empty macrophages compared to those con-
taining NS loaded macrophages. Laser treatment not only
caused the destruction of the loaded Ma but also was toxic
to the surrounding tumor cells (Fig. 5c, d). In contrast,
spheroids containing empty Ma showed no signiﬁcant
increase in necrotic cells following laser irradiation com-
pared to nontreated controls (Fig. 5 a and b).
PTT effect on hybrid spheroid growth
Hybrid spheroids were allowed to grow in culture for a
period of 12 days to determine their viability following
Fig. 2 TEM images of
nanoshell-loaded murine
macrophages. The nanoshells
are aggregated in vacuoles
dispersed throughout the
cytoplasm (a and b).
Magniﬁcation of a vacuole in
a show the high contrast
nanoshells. White arrows in
b indicate vacuoles containing
NS
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2
for 10 min. The kinetics of the hybrid spheroid growth
pattern is shown in Fig. 6A. Hybrid spheroids containing
empty Ma (b) displayed no signiﬁcant decrease in their
growth pattern following PTT compared to that observed
for spheroids containing either empty (a) or NS loaded
(c) Ma receiving no radiation (P = 0.074). In contrast
PTT had a highly signiﬁcant effect on NS loaded Ma
spheroid survival (d, e) with a complete cessation of
growth in all of the spheroids examined (P\0.001).
There were no signiﬁcant differences in the effects of PTT
on spheroids containing either 50% (d) or 20% (e) Ma of
the total number of cells (P = 0.29), both showing a
signiﬁcant reduction in size from day 1 to day 12 after
laser treatment. Since the spheroids were generated with
5 9 10
3 tumor cells, 1 9 10
3 loaded Ma were sufﬁcient to
cause none of the spheroids to survive PTT. This was in
contrast to non laser treated spheroids which demonstrated
rapid growth, increasing their average diameter from 700
to 1100 lm, corresponding to an increase in volume of
6–7 times.
PTT effect on Ma inﬁltrated formed spheroids
The effects of PTT on spheroids inﬁltrated in co-culture
with empty or NS loaded Ma was also evaluated (Fig. 6B).
Spheroids were formed containing 5 9 10
3 tumor cells.
48 h after formation, individual spheroids were co-incu-
bated with 2 9 10
4 Ma for 2 or 18 h in the wells of round
bottomed 96 well plates. The spheroids were washed and
transferred to new wells to remove non-incorporated NS
loaded Ma. Following either 2 or 18 h of co-incubation,
sufﬁcient numbers of NS loaded Ma inﬁltrated into the
spheroid to completely inhibit their growth following PTT
(Fig. 6B c, d) compared to non treated controls or laser
treated controls containing empty Ma (P\0.001; Fig. 6B,
a, b).
The effects of increasing laser irradiance are demon-
strated in Fig. 7. On day 2 following spheroid formation,
2 9 10
4 empty or NS loaded Ma were added to each well
for an additional 24 h. The spheroids were carefully
washed and transferred to new plates and irradiated with
either a 5 mm (2 and 7 W/cm
2) or a 3 mm laser spot size
Fig. 3 Two photon
ﬂuorescence micrograph of
a empty or b nanoshell loaded
Ma. Cell nucleus stained with
Hoechst 33342 (blue),
Cytoplasm stained with PKH26
Red Fluorescent (red),
nanoshell aggregates inside Ma
shown by white reﬂectance
(white arrows)
Fig. 4 Two photon ﬂuorescence image of a hybrid (tumor cell/Ma)
spheroid, b Ma inﬁltrated spheroid. c nanoshell loaded macrophage
migration into tumor spheroids. Cell nucleus stained with Hoechst
33342 (blue), Ma cytoplasm stained with PKH26 Red Fluorescent
(red), nanoshell aggregates inside Ma shown by white reﬂectance.
Images were acquired at a depth of approximately 80 lm. The ﬁeld of
view for images 600 9 600 lm( a, b)4 09 40 lm( c)
J Neurooncol (2011) 104:439–448 443
123for the higher powers and incubated for an additional
14 days. At laser irradiances of 7 W/cm
2, signiﬁcant
inhibition of spheroid growth was observed (P = 0.0023)
compared to non treated controls. At laser power levels of
14 or 28 W/cm
2 complete suppression of spheroid growth
was observed (P\0.001) At the highest power density
(28 W/cm
2) employed, spheroids were seen to explode
after only seconds of NIR irradiation. In contrast, at all of
the power densities used, no signiﬁcant growth inhibition
or delay was seen for spheroids containing either empty Ma
or tumor cells alone compared to spheroids receiving no
treatment (P = 0.47). Similar results to those observed
with a 10 min laser exposure (Fig. 7) were also obtained
with an exposure of 5 min (data not shown).
Hybrid spheroids were generated with 5 9 10
2 loaded
Ma concentrated in the core of the spheroid. NIR irradia-
tion at low power for 1 min had little toxic effect (Fig. 8a)
but at an irradiance of 28 W/cm
2 the entire core of the
spheroid that contained the loaded Ma was completely
obliterated (Fig. 8b, white arrow). Live/dead assay of these
spheroids revealed that the surrounding cells in the outer
rim, which contained no NS loaded Ma, were affected to a
much less dramatic degree (red arrow Fig. 8b).
Discussion
Tumor resection is usually the ﬁrst modality employed in
the treatment of gliomas. Employing the improved surgical
Fig. 5 Live/deadassayofPTTtreatedhybridandinﬁltratedspheroids.
Two photon micrographs were made at planes 100 lm into the
spheroids with simultaneous excitation of the two dyes (Blue live, red
dead) a Tumor ? Ma/NS control. b Tumor ? Ma ? PTT,
c Tumor ? Ma/NS ? PTT, d Tumor ? Ma/NS ? PTT. Images a, b,
c show hybrid spheroids (5 9 10
3 tumor cells ?2.5 9 10
3 Ma). Image
dshowsaMa/NSinﬁltratedspheroid(24 hco-incubation).PTT:14 W/
cm
2, 10 min. Images in a–c taken 12 days post PTT, image in d taken
2 days post PTT. Images were acquired at a depth of approximately
60–80 lm. The ﬁeld of view for images 600 9 600 lm
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Fig. 6 Kinetics of spheroid growth as a % initial size following PTT.
A Hybrid spheroids were formed containing 5 9 10
3 tumor cells with
2.5 9 10
3 empty Ma (a, b), loaded Ma/NS (d, c),o r19 10
3 loaded
Ma/NS (e) PTT 14 W/cm
2, 10 min (b, d, e). B Spheroids were
formed containing 5 9 10
3 tumor cells. 48 h after formation,
individual spheroids were co-incubated with 2 9 10
4 empty Ma for
18 h (b) or NS loaded Ma for 2 h. (d)o r1 8h .( a, c) in the wells of
round bottomed 96 well plates. The spheroids were washed and
transferred to new wells to remove non-incorporated NS. PTT, 14 W/
cm
2, 10 min (b, c, d)
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123techniques now available, the incidence of gross tumor
resection, as deﬁned by a negative post operative MRI, has
greatly increased [21–23]. Nevertheless, the great majority
of glioma patients do suffer a recurrence of their tumors
leading to their poor prognosis. The therapeutic goal fol-
lowing surgical resection therefore is the elimination of
inﬁltrating tumor cells remaining in the margins of the
resection cavity, where most tumor recurrences occur,
while minimizing damage to normal brain. One of the
many obstacles to effective treatment of malignant brain
tumors is limited transport of anti-tumor agents through
both brain and brain tumor capillaries due to the blood–
brain barrier (BBB) and the blood–brain tumor barrier
(BBTB), the latter which retains many BBB characteristics.
A number of methods have been explored for enhancing
drug delivery across the BBB/BBTB [24–26]. The ability
of macrophages to migrate and accumulate within, and at
the periphery, of brain tumors renders them attractive
vehicles for the delivery of anti tumor agents including
nanoparticles. Ma trafﬁcking into the CNS is a highly
regulated function and is dependent on cell–cell interac-
tions that involve tumor cells, endothelial cells and astro-
cytes. In addition, the local releases of factors that promote
BBB permeability also play a role. The use of macrophages
as a cell-based delivery vehicle for nanoparticles stemmed
from the observations that the iv administration of para-
magnetic nanoparticles for MRI, were ingested by endog-
enous macrophages that subsequently migrated and
accumulated in and around tumors [27–29] This was also
the case when exogenous in vitro labeled macrophages
were injected iv. [11].
The primary objective of this study was to examine the
ability of macrophages to act as vehicles that could deliver
a sufﬁcient quantity of gold nanoshells into glioma tumor
spheroids for efﬁcient PTT. It was hypothesized that: (1)
macrophages can efﬁciently take up bare or PEGylated
gold NS, (2) nanoshell-loaded macrophages could inﬁltrate
glioma spheroids following co-incubation to the same
degree as empty Ma, (3) NIR laser irradiation of NS loaded
Ma inﬁltrated spheroids would result in signiﬁcant growth
inhibition while spheroids inﬁltrated with empty macro-
phages would be undamaged. We have chosen to use this
simple in vitro spheroid model since it eliminates many of
the problems encountered with monolayer or animal stud-
ies. Multicell spheroids are three-dimensional aggregates
of tumor cells that mimic micro-tumors prior to their vas-
cularization. Tumor cells within spheroids show a higher
degree of morphological and functional differentiation than
cells grown in monolayer culture. They also display growth
kinetics, metabolic rates, and resistance to radiotherapy and
photodynamic and chemotherapy similar to tumor cells in
vivo [for review see 19].
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Fig. 7 Effects of laser power on spheroid growth. Preformed
spheroids incubated with either empty (Tc ? Ma) or NS loaded
(Tc ? Ma/NS) Ma for 24 h, transferred and irradiated with increasing
irradiance for 10 min. The values shown represent the average
diameter following 14 days of incubation minus the initial diameter
of the spheroid (D spheroid growth)
Fig. 8 Two photon micrograph of hybrid spheroid formed with
5 9 10
2 Ma/NS concentrated in the core of the spheroid. a PTT 7 W/
cm
2 b PTT 28 W/cm
2 Laser spot size 3 mm, spheroid dia. 0.7 mm.
Treatment time 1 min. Images taken 24 h. following treatment. At
high irradiance (b) the core of the spheroid was completely
obliterated (white arrow). Live/dead assay of these spheroids revealed
that the surrounding cells in the outer rim, which contained no NS
loaded Ma, were affected to a much less dramatic degree (red arrow
Fig. 8b). Images were acquired at a depth of approximately 80 lm.
The ﬁeld of view for images 600 9 600 lm
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123The ability of Ma to phagocytose several types of
nanoparticles including gold nanoshells, the ﬁrst step in the
cell vectorization of NS, has been studied in several pre-
vious publications [14, 29]. When nanoparticles are injec-
ted into the circulation they are quickly engulfed by ﬁxed
(Kupffer cells), spleen, and bone marrow as well as cir-
culating monocytes/macrophages and are rapidly removed
from the circulation. Various strategies have been devel-
oped in order to prolong their systemic blood circulation
time allowing more of these particles to be delivered to the
tumor site. Among the various polymers used for this
purpose, polyethylene glycol (PEG) is currently the most
popular and the most effective in prolonging circulation
time of nanoparticles [29, 30] On the other hand, the
strategy of employing in vitro loading of macrophage
vectors would dictate a maximum uptake of nanoparticles
by the macrophages. Although the % uptake of bare or
PEGylated nanoshells was 16 and 4% respectively,
PEGylated nanoshells were available in higher concentra-
tion since they have a much lower tendency to aggregate.
Therefore the total amount of PEGylated nanoshells taken
up by the macrophages was more than 8 times that of bare
nanoshells. Additionally, incorporation of nanoshells into
the macrophages proved to be nontoxic, as judged with
live/dead assays, probably due to the biocompatibility of
gold. Spheroids containing empty or NS loaded Ma were
produced by two methods. Hybrid spheroids containing
mixtures of tumor cells and Ma were centrifuged together
in the wells of microplates. The uniform distribution of
loaded Ma inﬁltrating into the spheroids demonstrated in
this study is in contrast to previous workers [13, 14] who
had shown that macrophages inﬁltrate the spheroid and
accumulate in the inner hypoxic rim around the central
necrosis. This also appears to be the case in vivo since
tumor associated macrophages (TAMs) have also been
seen in high density in hypoxic tumor areas, where it is
hypothesized that, being phagocyte scavenger cells, they
are attracted by signals released by cells undergoing
necrosis. In addition, it has been shown that hypoxic tumor
cells recruit TAMs by an increased rate of production of
macrophage chemo attractants such as VEGF. Following
their migrations, hypoxic tumor cells entrap TAMs by
down regulating chemokine receptors and chemo-attrac-
tants and up regulating macrophage migration inhibitory
factor. This also seems to be the case in GBM but since
most or all of the necrotic core often found in gliomas is
removed during cytoreductive surgery, it is the TAMs, that
have inﬁltrated the BAT region, which are of therapeutic
interest. The even distribution of inﬁltrating Ma found in
our results, in contrast to previous work, can be explained
by the observation that spheroids formed by the centrifu-
gation method possess few dead cells in their core region
during the ﬁrst 24–48 h. Since the majority of our co-
incubation studies were done 48 h following spheroid
formation, they did not have the extensive necrotic core
usually found in spheroids grown in the conventional
manner, formed over a protracted time interval usually
1–2 weeks prior to their use.
Most biological tissue lack NIR-absorbing chromoph-
ores, thus permitting transmission of NIR light
(700–1,000 nm). Therefore, normal tissue along the laser
path should suffer minimal thermal damage, which is not
the case for radiofrequency (RF) or magnetic thermal
ablation [31, 32]. Spheroids containing empty Ma were not
affected by even the highest laser irradiances tested (28 W/
cm
2) Live/dead assays clearly demonstrated similar num-
bers of dead cells in spheroids containing empty Ma
independent of laser treatment (Fig. 5a, b), in sharp con-
trast to the effects of NIR on spheroids containing loaded
Ma where the overwhelming majority of tumor cells were
dead (Fig. 5c, d).
The ability of PTT to only affect tumor cells adjacent to
NS loaded Ma could be dramatically demonstrated in
hybrid spheroids where the NS loaded Ma were constrained
to the core region. Complete ablation of the core region
was obtained (Fig. 8) while the surrounding tumor cells
were still viable. Since the laser beam size was 3 mm and
the spheroid had a diameter of 0.7 mm, the entire spheroid
received full laser exposure but only the core where the NS
loaded Ma were located was ablated.
Comparable spheroid models have been employed in
several of our previous studies on the effects of photody-
namic therapy (PDT) on spheroid growth [19]. Identical
PDT parameters on multiple replicate cultures often led to
a survival dichotomy with a majority of cultures showing
no survival but with a signiﬁcant percentage of spheroids
surviving treatment. This effect was clearly light ﬂuence
dependent and treatment often led to a growth delay but not
to a growth cessation. PDT is a very oxygen dependent
toxic modality and, like ionizing radiation, does not have a
dramatic effect on hypoxic cells, which are found in the
more central portions of the spheroids. This did not seem to
be the case for PTT where growth delay was not observed
and all replicate cultures completely ceased to grow and, in
fact, contracted in size following treatment (Fig. 6A, B).
Irreversible thermal damage to cells is not oxygen depen-
dent but is caused by inactivation of vital enzymes, struc-
tural protein denaturation, and conformational changes
induced in RNA and DNA that are so severe that the usual
repair mechanisms are themselves inactivated. The result-
ing disruption of organelles, and especially cell mem-
branes, is incompatible with survival [33, 34]. In principle,
PTT should be effective on both well oxygenated and
hypoxic cancer cells, providing adequate heating occurs i.e.
temperatures over 50C for a sufﬁcient time interval. In
many of the laser exposed cultures, the spheroids
446 J Neurooncol (2011) 104:439–448
123containing loaded Ma were transformed to an amorphous
mass indicating that the collagen in the extracellular matrix
in the tissue had undergone hyalinization, a clear heat
induced process.
Although NS can inﬁltrate into spheroids [35, 36], and
spheroids incorporating NS could be produced by the
centrifugation method, PTT following direct incorporation
of NS was not explored since NS, like the ones investi-
gated in this study, do not cross the intact BBB [18]. In
contrast, macrophages readily traverse the patent BBB
where residual glioma cells are found following surgical
resection and therefore these immune cells have potential
application as delivery vehicles in therapeutic applica-
tions. Nanoparticles tend to accumulate in tumors by
virtue of the so-called enhanced permeability and reten-
tion effect due to poorly organized and fenestrated tumor
vasculature combined with poor lymphatic drainage.
Although nanoparticles can penetrate the leaky vascula-
ture in tumors, the extracellular matrix of solid tumors
presents a transport barrier that limits penetration,
decreasing the efﬁcacy of nanoparticle mediated therapies
[36]. Cells on the other hand, can migrate through the
extracellular matrix, especially inﬂammatory cells like
Ma. Ma injected i.v will either track to the tumor site or
be eliminated in the reticulo-endothelial system. Methods
which would increase the ability of exogenous loaded
macrophages to migrate to the BAT, making them avail-
able for postoperative therapeutic modalities, are key to
the possible implementation of this technique, in future
patient treatments, and are the subject of ongoing in vitro
and animal studies [37].
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